
FDA cites ‘significant’ PFAS safety data gaps in report
The US Food and Drug Administration says it cannot determine whether most perfluoroalkyl and polyfluoroalkyl substances (PFAS) used in cosmetic products are safe, citing major gaps in available toxicological data in a congressionally mandated review.





















